Lv64
3150 积分 2024-07-02 加入
Resmetirom therapy for metabolic dysfunction-associated steatotic liver disease: October 2024 updates to AASLD Practice Guidance
1天前
待确认
Pueraria montana var. lobata Root Extract Alleviates Metabolic Dysfunction‐Associated Steatotic Liver Disease by Increasing Mitochondrial β‐Oxidation and Mitochondrial‐Peroxisome Contact
2天前
已完结
Scutellarin Alleviates Hepatic Steatosis by Autophagy‐Mediated NCoR1 / PPARα ‐Driven Fatty Acid β‐Oxidation and Enhancing Peroxisome Biogenesis
2天前
已完结
PEMT-mediated phospholipid imbalance promotes age-associated metabolic dysfunction-associated steatotic liver disease progression
2天前
已完结
Biologically Intact Therapeutic Exosomes From Human Hepatic Progenitor Cells for Liver Diseases
2天前
已完结
Dietary supplement Forskolin improves MASLD through hepatocyte-macrophage crosstalk via the GLUT1/ABCF1-HNF4α axis
2天前
已完结
Fenofibrate promotes erucic acid metabolism by peroxisome enzyme EHHADH activation alleviating high-fat diet–induced steatotic liver disease
2天前
已完结
Integrated Plasma Proteomics and Functional Analyses Reveal Hepatic CDHR2 as a Potential Therapeutic Target in MASLD
2天前
已完结
Hydronidone Alleviates Metabolic Dysfunction‐Associated Fatty Liver Disease by Inhibiting CD36 Expression
2天前
已完结
Semaglutide Ameliorates Hepatocyte Steatosis in a Cell Co-Culture System by Downregulating the IRE1α-XBP1-C/EBPα Signaling Pathway in Macrophages
3天前
已完结
皖公网安备34019202002308
